Old Web
English
Sign In
Acemap
>
authorDetail
>
N. Funami
N. Funami
Medicine
Carboplatin
non-small cell lung cancer (NSCLC)
Pathology
Pharmacodynamics
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P15.03 A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC
2021
Journal of Thoracic Oncology
K Goto
T. Hida
N. Funami
R. Iwasawa
S. Mita
Y. Botilde
A. Yamashita
Y Inoh
Nahor Haddish-Berhane
John Xie
A Roshak
Roland Elmar Knoblauch
Y Ohe
Show All
Source
Cite
Save
Citations (2)
Plasma biomarker analysis of a phase I trial of ASA404 (vadimezan) in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer (NSCLC).
2010
Journal of Clinical Oncology
M. M. Shi
N. Funami
M. Steed
M. Motwani
Douglas Robinson
E DiTomaso
J. C. Barrett
R. J. Waltzman
J Klimovsky
K. Kobayashi
Show All
Source
Cite
Save
Citations (1)
1